Literature DB >> 119267

Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: a double-blind controlled study.

T Okuma, K Inanaga, S Otsuki, K Sarai, R Takahashi, H Hazama, A Mori, M Watanabe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 119267     DOI： 10.1007/bf00428308

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  10 in total

1.  Modifications by lithium of behavioral responses to methamphetamine and tetrabenazine.

Authors:  T Furukawa; I Ushizima; N Ono
Journal:  Psychopharmacologia       Date:  1975-06-19

2.  Lithium salts in the treatment of psychotic excitement.

Authors:  J F J CADE
Journal:  Med J Aust       Date:  1949-09-03       Impact factor: 7.738

3.  Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness.

Authors:  R F Prien; C J Klett; E M Caffey
Journal:  Arch Gen Psychiatry       Date:  1973-09

4.  Relationship between serum lithium level and clinical response in acute mania treated with lithium.

Authors:  R F Prien; E M Caffey; C J Klett
Journal:  Br J Psychiatry       Date:  1972-04       Impact factor: 9.319

5.  Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group.

Authors:  R F Prien; E M Caffey; C J Klett
Journal:  Arch Gen Psychiatry       Date:  1972-02

6.  Comparative effects of lithium and chlorpromazine in the treatment of acute manic states.

Authors:  G Johnson; S Gershon; E I Burdock; A Floyd; L Hekimian
Journal:  Br J Psychiatry       Date:  1971-09       Impact factor: 9.319

7.  Comparison of efficacy of lithium carbonate and chlorpromazine in mania. Report of collaborative study group on treatment of mania in Japan.

Authors:  R Takahashi; A Sakuma; K Itoh; H Itoh; M Kurihara
Journal:  Arch Gen Psychiatry       Date:  1975-10

8.  Carbamazepine for epilepsy. A controlled prospective evaluation.

Authors:  J J Cereghino; J T Brock; J C Van Meter; J K Penry; L D Smith; B G White
Journal:  Neurology       Date:  1974-05       Impact factor: 9.910

9.  The effects of carbamazepine on patients with psychomotor epilepsy: results of a double-blind study.

Authors:  E A Rodin; C S Rim; P M Rennick
Journal:  Epilepsia       Date:  1974-12       Impact factor: 5.864

10.  Anti-manic and prophylactic effects of carbamazepine (Tegretol) on manic depressive psychosis. A preliminary report.

Authors:  T Okuma; A Kishimoto; K Inoue; H Matsumoto; A Ogura
Journal:  Folia Psychiatr Neurol Jpn       Date:  1973
  10 in total
  26 in total

Review 1.  Therapeutic drug monitoring of psychotropic medications.

Authors:  P B Mitchell
Journal:  Br J Clin Pharmacol       Date:  2000-04       Impact factor: 4.335

2.  4-aminopyridine and barium chloride attenuate the anti-epileptic effect of carbamazepine in hippocampal slices.

Authors:  H Olpe; C N Kolb; A Hausdorf; H L Haas
Journal:  Experientia       Date:  1991-03-15

3.  Metabolic interaction between imipramine and carbamazepine in vivo and in vitro in rats.

Authors:  W Daniel; K J Netter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-01       Impact factor: 3.000

4.  Interaction of carbamazepine and other drugs with adenosine (A1 and A2) receptors.

Authors:  Y Fujiwara; M Sato; S Otsuki
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 5.  Review of pharmacological treatment in mood disorders and future directions for drug development.

Authors:  Xiaohua Li; Mark A Frye; Richard C Shelton
Journal:  Neuropsychopharmacology       Date:  2011-09-07       Impact factor: 7.853

Review 6.  The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm.

Authors:  Konstantinos N Fountoulakis; Lakshmi Yatham; Heinz Grunze; Eduard Vieta; Allan Young; Pierre Blier; Siegfried Kasper; Hans Jurgen Moeller
Journal:  Int J Neuropsychopharmacol       Date:  2017-02-01       Impact factor: 5.176

Review 7.  Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry.

Authors:  Konstantinos N Fountoulakis; Siegfried Kasper; Ole Andreassen; Pierre Blier; Ahmed Okasha; Emanuel Severus; Marcio Versiani; Rajiv Tandon; Hans-Jürgen Möller; Eduard Vieta
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-06       Impact factor: 5.270

Review 8.  Thirty years of clinical experience with carbamazepine in the treatment of bipolar illness: principles and practice.

Authors:  Robert M Post; Terence A Ketter; Thomas Uhde; James C Ballenger
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

9.  Pharmacokinetic interaction between carbamazepine and neuroleptics after combined prolonged treatment in rats.

Authors:  W Daniel; L Janczar; L Danek; W Legrum; K J Netter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-05       Impact factor: 3.000

Review 10.  The manic syndrome: factors which may predict a patient's response to lithium, carbamazepine and valproate.

Authors:  S C Dilsaver; A C Swann; A M Shoaib; T C Bowers
Journal:  J Psychiatry Neurosci       Date:  1993-03       Impact factor: 6.186
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.